<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Normal Aortic Anatomy & Indexing - Professor Atef Allam</title>
    
    <!-- Fonts -->
    <link href='https://fonts.googleapis.com/css2?family=Open+Sans:wght@300;400;600;700&display=swap' rel='stylesheet'>
    <link href='https://fonts.googleapis.com/css2?family=Roboto:wght@100;300;400;500;700;900&display=swap' rel='stylesheet'>
    <link href='https://fonts.googleapis.com/css2?family=Lato:wght@100;200;300;400;600;700;900&display=swap' rel='stylesheet'>
    
    <!-- Font Awesome -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
    
    <!-- Bootstrap -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet">
    
    <link rel="stylesheet" href="../css/style.css">
</head>

<body>
    <!-- Navigation -->
    <nav class="main-navigation">
        <div class="nav-container">
            <div class="nav-brand">
                <a href="../index.html">Prof. Atef Allam</a>
            </div>
            
            <div class="nav-menu">
                <ul class="nav-list">
                    <li class="nav-item">
                        <a href="../index.html#about" class="nav-link">About</a>
                    </li>
                    <li class="nav-item">
                        <a href="../index.html#expertise" class="nav-link">Expertise</a>
                    </li>
                    <li class="nav-item">
                        <a href="../index.html#publications" class="nav-link">Publications</a>
                    </li>
                    <li class="nav-item dropdown-container">
                        <a href="../index.html#presentations" class="nav-link dropdown-toggle">
                            Presentations <i class="fa fa-chevron-down"></i>
                        </a>
                        <div class="mega-dropdown">
                            <div class="dropdown-section">
                                <h4>Aortic Disease & Management</h4>
                                <div class="dropdown-subsection">
                                    <ul>
                                        <li><a href="aortic-biopsy.html">Aortic Biopsy Techniques</a></li>
                                        <li><a href="aortic-management.html">Aortic Disease Management Update</a></li>
                                        <li><a href="aortic-anatomy.html">Normal Aortic Anatomy & Indexing</a></li>
                                        <li><a href="aortic-diameters.html">Normal Aortic Diameters by Segment</a></li>
                                        <li><a href="petti-coat.html">PETTICOAT Technique</a></li>
                                    </ul>
                                </div>
                            </div>
                            <div class="dropdown-section">
                                <h4>Vascular Biomechanics & Physics</h4>
                                <div class="dropdown-subsection">
                                    <ul>
                                        <li><a href="biomechanical-rationale.html">Biomechanical Rationale</a></li>
                                        <li><a href="biomechanics-remodeling.html">Biomechanics in Tissue Remodeling</a></li>
                                        <li><a href="vascular-biomechanics.html">Vascular Biomechanics & Stress</a></li>
                                        <li><a href="wall-tension.html">Wall Tension & Surgical Planning</a></li>
                                        <li><a href="hypertension-shear.html">Hypertension, Shear Stress & Dissection</a></li>
                                    </ul>
                                </div>
                            </div>
                            <div class="dropdown-section">
                                <h4>Interventional Techniques</h4>
                                <div class="dropdown-subsection">
                                    <ul>
                                        <li><a href="balloon-atheroma.html">Balloon Dilation of Atheroma</a></li>
                                        <li><a href="balloon-strategies.html">Balloon Dilation Strategies</a></li>
                                        <li><a href="fea-cases.html">FEA Case Examples</a></li>
                                    </ul>
                                </div>
                            </div>
                            <div class="dropdown-section">
                                <h4>Pathophysiology & Research</h4>
                                <div class="dropdown-subsection">
                                    <ul>
                                        <li><a href="beyond-tgf.html">Beyond TGF-β/MMP</a></li>
                                        <li><a href="fcda-comprehensive.html">FCDA Comprehensive</a></li>
                                        <li><a href="fcda-pathophysiology.html">FCDA Pathophysiology & Management</a></li>
                                        <li><a href="fcda-predilection.html">FCDA Arterial Predilection</a></li>
                                        <li><a href="fcda-popliteal.html">FCDA Popliteal Biopsy</a></li>
                                        <li><a href="neointimal-hyperplasia.html">Neointimal Hyperplasia</a></li>
                                        <li><a href="nih-comprehensive.html">NIH Comprehensive</a></li>
                                        <li><a href="nih-future.html">NIH Future Therapies</a></li>
                                        <li><a href="tissue-remodeling.html">Tissue Remodeling</a></li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </li>
                    <li class="nav-item">
                        <a href="../index.html#research" class="nav-link">Research</a>
                    </li>
                    <li class="nav-item">
                        <a href="../index.html#teaching" class="nav-link">Teaching</a>
                    </li>
                    <li class="nav-item">
                        <a href="../index.html#awards" class="nav-link">Awards</a>
                    </li>
                </ul>
            </div>
        </div>
    </nav>

    <!-- Presentation Header -->
    <header class="presentation-header">
        <div class="container">
            <div class="row">
                <div class="col-12">
                    <h1 class="presentation-title">Normal Aortic Anatomy and Indexing to Height/BSA/CSA</h1>
                    <p class="presentation-subtitle">Advanced Vascular Surgery Presentation</p>
                    <div class="presentation-meta">
                        <span><i class="fa fa-calendar"></i> Medical Presentation</span>
                        <span><i class="fa fa-user-md"></i> Professor Atef Allam</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Presentation Content -->
    <main class="presentation-content">
        <div class="container">
            <div class="row">
                <div class="col-12">
                    
                    <!-- Section 1: Normal Aortic Anatomy and Indexing -->
                    <section class="content-section">
                        <h2>1. Normal Aortic Anatomy and Indexing</h2>
                        
                        <p class="content-text">
                            The aorta's diameter varies by age, sex, and body size. Indexing aortic size to <span class="medical-term">body surface area (BSA)</span> or height improves risk stratification, especially in smaller individuals (e.g., women, Asians).
                        </p>

                        <div class="recommendation-box">
                            <h3>Normal Diameters (2022 ACC/AHA Guidelines):</h3>
                            <ul>
                                <li><span class="medical-term">Ascending aorta:</span> <span class="percentage">≤3.5 cm</span> (men), <span class="percentage">≤3.3 cm</span> (women).</li>
                                <li><span class="medical-term">Descending aorta:</span> <span class="percentage">≤2.8 cm</span>.</li>
                                <li><span class="medical-term">Abdominal aorta:</span> <span class="percentage">≤3.0 cm</span>.</li>
                            </ul>
                        </div>

                        <div class="subsection">
                            <h3>Aortic Size Index (ASI):</h3>
                            
                            <div class="key-points">
                                <h3>Formula:</h3>
                                <p style="text-align: center; font-family: 'Courier New', monospace; font-size: 1.2em; font-weight: 600; margin: 20px 0;">
                                    ASI = Max aortic diameter (cm) / BSA (m²)
                                </p>
                            </div>

                            <ul>
                                <li>ASI <span class="percentage">≥2.75 cm/m²</span> (ascending aorta) indicates higher rupture risk.</li>
                                <li><span class="medical-term">Height-indexing:</span> Some studies suggest aortic diameter/height (cm/m) <span class="percentage">>1.8–2.0</span> as a risk threshold.</li>
                            </ul>
                        </div>

                        <div class="challenge-box">
                            <h3>Clinical Implications:</h3>
                            <ul>
                                <li><span class="medical-term">Marfan syndrome:</span> Intervention considered at ASI <span class="percentage">≥2.5 cm/m²</span> even if absolute diameter is <span class="percentage"><5.0 cm</span>.</li>
                                <li><span class="medical-term">Small-stature patients:</span> Absolute diameter thresholds may underestimate risk; indexing is critical.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 2: Aortic Imaging Recommendations -->
                    <section class="content-section">
                        <h2>2. Aortic Imaging Recommendations</h2>
                        
                        <div class="subsection">
                            <h3>Modalities & Frequency</h3>
                            
                            <div class="challenge-box">
                                <h3>Echocardiography (TTE/TEE):</h3>
                                <ul>
                                    <li>First-line for ascending aorta (e.g., bicuspid valve, Marfan).</li>
                                    <li><span class="medical-term">Surveillance:</span> Every <span class="percentage">6–12 months</span> if high-risk (e.g., growth <span class="percentage">>0.3 cm/year</span>).</li>
                                </ul>
                            </div>

                            <div class="recommendation-box">
                                <h3>CT Angiography (CTA):</h3>
                                <ul>
                                    <li>Gold standard for dissection, aneurysms, pre-op planning.</li>
                                    <li>Low-dose protocols reduce radiation (e.g., ECG-gated CTA).</li>
                                </ul>
                            </div>

                            <div class="key-points">
                                <h3>MRI/MRA:</h3>
                                <ul>
                                    <li>Preferred for young patients, serial monitoring (no radiation).</li>
                                    <li><span class="medical-term">4D Flow MRI:</span> Assesses wall shear stress, predicts dissection risk.</li>
                                </ul>
                            </div>

                            <div class="challenge-box">
                                <h3>PET-CT:</h3>
                                <p class="content-text">For aortitis (e.g., FDG uptake in vasculitis).</p>
                            </div>
                        </div>

                        <div class="recommendation-box">
                            <h3>2022 ESC Imaging Guidelines:</h3>
                            <ul>
                                <li>Baseline imaging for all first-degree relatives of aortic dissection patients.</li>
                                <li>Annual imaging if aorta <span class="percentage">>4.0 cm</span> or genetic aortopathy.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 3: Change in Size Threshold for TAA Repair -->
                    <section class="content-section">
                        <h2>3. Change in Size Threshold for TAA Repair & Supporting Evidence</h2>
                        
                        <div class="subsection">
                            <h3>Previous vs. Current Thresholds</h3>
                            
                            <div class="table-container">
                                <table>
                                    <thead>
                                        <tr>
                                            <th>Population</th>
                                            <th>Old Threshold</th>
                                            <th>2022 ACC/AHA Threshold</th>
                                            <th>Evidence</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>General population</td>
                                            <td>≥5.5 cm</td>
                                            <td>≥5.5 cm</td>
                                            <td>IRAD registry data</td>
                                        </tr>
                                        <tr>
                                            <td>Bicuspid aortic valve</td>
                                            <td>≥5.0 cm</td>
                                            <td>≥5.0 cm</td>
                                            <td>Increased dissection risk at smaller sizes</td>
                                        </tr>
                                        <tr>
                                            <td>Marfan syndrome</td>
                                            <td>≥5.0 cm</td>
                                            <td>≥4.5–5.0 cm</td>
                                            <td>GEN-TAC registry</td>
                                        </tr>
                                        <tr>
                                            <td>Loeys-Dietz syndrome</td>
                                            <td>≥4.5 cm</td>
                                            <td>≥4.2–4.5 cm</td>
                                            <td>High rupture risk</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Key Studies Supporting Lower Thresholds</h3>
                            
                            <ul>
                                <li><span class="medical-term">German Marfan Registry (2021):</span> <span class="percentage">25%</span> of dissections occurred at <span class="percentage"><5.0 cm</span>.</li>
                                <li><span class="medical-term">IRAD Substudy (2022):</span> Bicuspid valve patients had dissections at <span class="percentage">4.6–5.0 cm</span>.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 4: AAA & Thoracoabdominal Aneurysm Guidelines -->
                    <section class="content-section">
                        <h2>4. AAA & Thoracoabdominal Aneurysm (TAAA) Guidelines</h2>
                        
                        <div class="subsection">
                            <h3>AAA (2023 SVS Update)</h3>
                            
                            <div class="recommendation-box">
                                <h3>Intervention Threshold:</h3>
                                <ul>
                                    <li><strong>Men:</strong> <span class="percentage">≥5.5 cm</span> (EVAR preferred if anatomy permits).</li>
                                    <li><strong>Women:</strong> <span class="percentage">≥5.0 cm</span> (higher rupture risk at smaller sizes).</li>
                                </ul>
                            </div>

                            <div class="challenge-box">
                                <h3>Surveillance:</h3>
                                <ul>
                                    <li><span class="percentage">3.0–3.9 cm:</span> Every 3 years.</li>
                                    <li><span class="percentage">4.0–5.4 cm:</span> Every 6–12 months.</li>
                                </ul>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>TAAA (2023 ESVS Guidelines)</h3>
                            
                            <ul>
                                <li><span class="medical-term">Open Repair:</span> Still gold standard for extensive Crawford I-III aneurysms.</li>
                                <li><span class="medical-term">F/B-EVAR:</span> Preferred for high-risk patients if <span class="percentage">≥4</span> experienced centers.</li>
                                <li><span class="medical-term">Spinal Cord Protection:</span> CSF drainage + staged repair reduces paraplegia risk.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 5: Type A Aortic Dissection Recommendations -->
                    <section class="content-section">
                        <h2>5. Type A Aortic Dissection (TAAD) Recommendations</h2>
                        
                        <div class="subsection">
                            <h3>Emergency Surgery:</h3>
                            <ul>
                                <li>Within <span class="percentage">6 hours</span> of symptom onset (mortality increases <span class="percentage">1–2%/hour</span> delay).</li>
                                <li><span class="medical-term">Frozen elephant trunk (FET):</span> Emerging hybrid approach for arch involvement.</li>
                            </ul>
                        </div>

                        <div class="subsection">
                            <h3>Medical Management Post-Op:</h3>
                            <ul>
                                <li><span class="drug-name">Beta-blockers</span> + <span class="drug-name">ARBs</span> (lifelong).</li>
                                <li>SBP target <span class="percentage"><120 mmHg</span> (2022 ESC).</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 6: Type B Aortic Dissection Recommendations -->
                    <section class="content-section">
                        <h2>6. Type B Aortic Dissection (TBAD) Recommendations</h2>
                        
                        <div class="table-container">
                            <table>
                                <thead>
                                    <tr>
                                        <th>Category</th>
                                        <th>Management</th>
                                        <th>Evidence</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Uncomplicated</td>
                                        <td>Medical (BB + ARB)</td>
                                        <td>INSTEAD-XL trial</td>
                                    </tr>
                                    <tr>
                                        <td>Complicated</td>
                                        <td>TEVAR</td>
                                        <td>ADSORB trial</td>
                                    </tr>
                                    <tr>
                                        <td>Chronic (>6 mo)</td>
                                        <td>TEVAR if growth >5.5 cm</td>
                                        <td>VALOR trial</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <p class="content-text">
                            <span class="medical-term">PETTICOAT Technique:</span> Improves false lumen thrombosis.
                        </p>
                    </section>

                    <!-- Section 7: IMH & PAU Management -->
                    <section class="content-section">
                        <h2>7. IMH & PAU Management</h2>
                        
                        <div class="subsection">
                            <h3>IMH:</h3>
                            <ul>
                                <li><span class="medical-term">High-risk features:</span> Ascending IMH, diameter <span class="percentage">>5.0 cm</span>, ulcer-like projections.</li>
                                <li><span class="medical-term">Treatment:</span> Surgery if ascending; TEVAR if descending + progression.</li>
                            </ul>
                        </div>

                        <div class="subsection">
                            <h3>PAU:</h3>
                            <ul>
                                <li><span class="medical-term">Intervention if:</span> Depth <span class="percentage">>10 mm</span>, diameter <span class="percentage">>20 mm</span>, recurrent symptoms.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 8: Physical Activity Recommendations -->
                    <section class="content-section">
                        <h2>8. Physical Activity Recommendations</h2>
                        
                        <div class="subsection">
                            <h3>Marfan/Loeys-Dietz:</h3>
                            <ul>
                                <li><strong>Avoid:</strong> Competitive sports, heavy lifting (<span class="percentage">>50%</span> body weight), Valsalva-inducing activities.</li>
                                <li><strong>Permitted:</strong> Low-moderate dynamic exercise (walking, swimming).</li>
                            </ul>
                        </div>

                        <div class="subsection">
                            <h3>Post-TEVAR/Repair:</h3>
                            <p class="content-text">
                                No contact sports (risk of stent-graft injury).
                            </p>
                        </div>
                    </section>

                    <!-- Section 9: Fluoroquinolone Use & Aortic Risk -->
                    <section class="content-section">
                        <h2>9. Fluoroquinolone Use & Aortic Risk</h2>
                        
                        <div class="challenge-box">
                            <h3>FDA Black Box Warning (2018):</h3>
                            <p class="content-text">
                                FQs (e.g., <span class="drug-name">ciprofloxacin</span>) increase aortic dissection/rupture risk (OR <span class="percentage">2–3x</span>).
                            </p>
                            
                            <div class="subsection">
                                <h4 style="color: #cccccc; margin: 15px 0 10px 0; font-size: 1.1em; font-weight: 600;">Mechanism:</h4>
                                <p class="content-text">MMP-9 upregulation + collagen degradation.</p>
                            </div>
                        </div>

                        <div class="recommendation-box">
                            <h3>2023 ESC Recommendations:</h3>
                            <ul>
                                <li>Avoid FQs in high-risk patients (aneurysm, genetic aortopathy).</li>
                                <li><span class="medical-term">Alternative antibiotics:</span> <span class="drug-name">Doxycycline</span>, <span class="drug-name">azithromycin</span>.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 10: Final Takeaway -->
                    <section class="content-section">
                        <h2>10. Final Takeaway</h2>
                        
                        <div class="key-points">
                            <h3>Summary:</h3>
                            <p class="content-text">
                                Aortic disease management is increasingly personalized, integrating imaging, genetics, and advanced endovascular techniques. Key shifts include:
                            </p>
                            <ul>
                                <li>Lower size thresholds for high-risk genetics.</li>
                                <li>TEVAR dominance in TBAD/descending aneurysms.</li>
                                <li>Strict BP control + activity restrictions to prevent progression.</li>
                            </ul>
                        </div>
                    </section>

                </div>
            </div>
        </div>
    </main>

    <!-- Footer -->
    <footer class="presentation-footer">
        <div class="container">
            <div class="row">
                <div class="col-12">
                    <div class="footer-content">
                        <div class="footer-divider"></div>
                        <div class="text-center copyright">
                            <span>© 2025 Professor Atef Allam. All rights reserved.</span>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </footer>

    <!-- Scripts -->
    <script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/js/bootstrap.bundle.min.js"></script>
    <script src="../js/main.js"></script>
</body>
</html>
